<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 600px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "#B0E57C", "id": "NCT06533384", "label": "NCT06533384", "shape": "dot", "title": "TRIAL Node: NCT06533384"}, {"color": "#FFA07A", "id": "COMPLETED", "label": "COMPLETED", "shape": "dot", "title": "BIOMARKER Node: COMPLETED"}, {"color": "#89CFF0", "id": "tissue factor-expressing solid tumors", "label": "tissue factor-expressing solid tumors", "shape": "dot", "title": "DRUG Node: tissue factor-expressing solid tumors"}, {"color": "#D3D3D3", "id": "endometrial cancer", "label": "endometrial cancer", "shape": "dot", "title": "OTHER Node: endometrial cancer"}, {"color": "#D3D3D3", "id": "triple negative breast cancer (tnbc)", "label": "triple negative breast cancer (tnbc)", "shape": "dot", "title": "OTHER Node: triple negative breast cancer (tnbc)"}, {"color": "#89CFF0", "id": "DRUG", "label": "DRUG", "shape": "dot", "title": "DRUG Node: DRUG"}, {"color": "#FFA07A", "id": "OTHER", "label": "OTHER", "shape": "dot", "title": "BIOMARKER Node: OTHER"}, {"color": "#B0E57C", "id": "NCT06036121", "label": "NCT06036121", "shape": "dot", "title": "TRIAL Node: NCT06036121"}, {"color": "#D3D3D3", "id": "metastatic castration-resistant prostate cancer", "label": "metastatic castration-resistant prostate cancer", "shape": "dot", "title": "OTHER Node: metastatic castration-resistant prostate cancer"}, {"color": "#B0E57C", "id": "NCT04683679", "label": "NCT04683679", "shape": "dot", "title": "TRIAL Node: NCT04683679"}, {"color": "#FFA07A", "id": "TMT212", "label": "TMT212", "shape": "dot", "title": "BIOMARKER Node: TMT212"}, {"color": "#B0E57C", "id": "NCT01372579", "label": "NCT01372579", "shape": "dot", "title": "TRIAL Node: NCT01372579"}, {"color": "#89CFF0", "id": "solid tumors", "label": "solid tumors", "shape": "dot", "title": "DRUG Node: solid tumors"}, {"color": "#D3D3D3", "id": "Exelixis", "label": "Exelixis", "shape": "dot", "title": "OTHER Node: Exelixis"}, {"color": "#89CFF0", "id": "Bevacizumab", "label": "Bevacizumab", "shape": "dot", "title": "DRUG Node: Bevacizumab"}, {"color": "#D3D3D3", "id": "eribulin mesylate", "label": "eribulin mesylate", "shape": "dot", "title": "OTHER Node: eribulin mesylate"}, {"color": "#D3D3D3", "id": "breast cancer", "label": "breast cancer", "shape": "dot", "title": "OTHER Node: breast cancer"}, {"color": "#D3D3D3", "id": "triple-negative breast cancer", "label": "triple-negative breast cancer", "shape": "dot", "title": "OTHER Node: triple-negative breast cancer"}, {"color": "#FFA07A", "id": "TNBC", "label": "TNBC", "shape": "dot", "title": "BIOMARKER Node: TNBC"}, {"color": "#D3D3D3", "id": "esophageal scc", "label": "esophageal scc", "shape": "dot", "title": "OTHER Node: esophageal scc"}, {"color": "#89CFF0", "id": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "label": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "shape": "dot", "title": "DRUG Node: As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy."}, {"color": "#B0E57C", "id": "NCT06136884", "label": "NCT06136884", "shape": "dot", "title": "TRIAL Node: NCT06136884"}, {"color": "#FFD700", "id": "Memorial Sloan Kettering Cancer Center", "label": "Memorial Sloan Kettering Cancer Center", "shape": "dot", "title": "SPONSOR Node: Memorial Sloan Kettering Cancer Center"}, {"color": "#B0E57C", "id": "NCT04925284", "label": "NCT04925284", "shape": "dot", "title": "TRIAL Node: NCT04925284"}, {"color": "#D3D3D3", "id": "Novartis Pharmaceuticals", "label": "Novartis Pharmaceuticals", "shape": "dot", "title": "OTHER Node: Novartis Pharmaceuticals"}, {"color": "#D3D3D3", "id": "epithelial ovarian cancer", "label": "epithelial ovarian cancer", "shape": "dot", "title": "OTHER Node: epithelial ovarian cancer"}, {"color": "#89CFF0", "id": "Pembrolizumab", "label": "Pembrolizumab", "shape": "dot", "title": "DRUG Node: Pembrolizumab"}, {"color": "#D3D3D3", "id": "Docetaxel", "label": "Docetaxel", "shape": "dot", "title": "OTHER Node: Docetaxel"}, {"color": "#89CFF0", "id": "Olaparib", "label": "Olaparib", "shape": "dot", "title": "DRUG Node: Olaparib"}, {"color": "#FFA07A", "id": "EGF816", "label": "EGF816", "shape": "dot", "title": "BIOMARKER Node: EGF816"}, {"color": "#FFA07A", "id": "ADRX-0706", "label": "ADRX-0706", "shape": "dot", "title": "BIOMARKER Node: ADRX-0706"}, {"color": "#D3D3D3", "id": "non small cell lung cancer", "label": "non small cell lung cancer", "shape": "dot", "title": "OTHER Node: non small cell lung cancer"}, {"color": "#B0E57C", "id": "NCT00203502", "label": "NCT00203502", "shape": "dot", "title": "TRIAL Node: NCT00203502"}, {"color": "#89CFF0", "id": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma", "label": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma", "shape": "dot", "title": "DRUG Node: colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"color": "#B0E57C", "id": "NCT02900664", "label": "NCT02900664", "shape": "dot", "title": "TRIAL Node: NCT02900664"}, {"color": "#D3D3D3", "id": "metastatic breast cancer", "label": "metastatic breast cancer", "shape": "dot", "title": "OTHER Node: metastatic breast cancer"}, {"color": "#D3D3D3", "id": "hormone receptor-positive breast cancer", "label": "hormone receptor-positive breast cancer", "shape": "dot", "title": "OTHER Node: hormone receptor-positive breast cancer"}, {"color": "#89CFF0", "id": "9 cycles of Camrelizumab as adjuvant therapy.", "label": "9 cycles of Camrelizumab as adjuvant therapy.", "shape": "dot", "title": "DRUG Node: 9 cycles of Camrelizumab as adjuvant therapy."}, {"color": "#D3D3D3", "id": "pancreatic cancer", "label": "pancreatic cancer", "shape": "dot", "title": "OTHER Node: pancreatic cancer"}, {"color": "#D3D3D3", "id": "Guangdong Provincial People\u0027s Hospital", "label": "Guangdong Provincial People\u0027s Hospital", "shape": "dot", "title": "OTHER Node: Guangdong Provincial People\u0027s Hospital"}, {"color": "#D3D3D3", "id": "scchn", "label": "scchn", "shape": "dot", "title": "OTHER Node: scchn"}, {"color": "#FFA07A", "id": "ACZ885", "label": "ACZ885", "shape": "dot", "title": "BIOMARKER Node: ACZ885"}, {"color": "#FFD700", "id": "University of Arkansas", "label": "University of Arkansas", "shape": "dot", "title": "SPONSOR Node: University of Arkansas"}, {"color": "#D3D3D3", "id": "A2A Pharmaceuticals Inc.", "label": "A2A Pharmaceuticals Inc.", "shape": "dot", "title": "OTHER Node: A2A Pharmaceuticals Inc."}, {"color": "#D3D3D3", "id": "high grade serous ovarian cancer", "label": "high grade serous ovarian cancer", "shape": "dot", "title": "OTHER Node: high grade serous ovarian cancer"}, {"color": "#FFA07A", "id": "RECRUITING", "label": "RECRUITING", "shape": "dot", "title": "BIOMARKER Node: RECRUITING"}, {"color": "#D3D3D3", "id": "Adcentrx Therapeutics", "label": "Adcentrx Therapeutics", "shape": "dot", "title": "OTHER Node: Adcentrx Therapeutics"}, {"color": "#FFA07A", "id": "XB002", "label": "XB002", "shape": "dot", "title": "BIOMARKER Node: XB002"}, {"color": "#D3D3D3", "id": "tnbc - triple-negative breast cancer", "label": "tnbc - triple-negative breast cancer", "shape": "dot", "title": "OTHER Node: tnbc - triple-negative breast cancer"}, {"color": "#89CFF0", "id": "Nivolumab", "label": "Nivolumab", "shape": "dot", "title": "DRUG Node: Nivolumab"}, {"color": "#D3D3D3", "id": "urothelial cancer", "label": "urothelial cancer", "shape": "dot", "title": "OTHER Node: urothelial cancer"}, {"color": "#FFA07A", "id": "CHEMICAL", "label": "CHEMICAL", "shape": "dot", "title": "BIOMARKER Node: CHEMICAL"}, {"color": "#D3D3D3", "id": "Radiation", "label": "Radiation", "shape": "dot", "title": "OTHER Node: Radiation"}, {"color": "#D3D3D3", "id": "Cyclophosphamide", "label": "Cyclophosphamide", "shape": "dot", "title": "OTHER Node: Cyclophosphamide"}, {"color": "#FFA07A", "id": "PDR001", "label": "PDR001", "shape": "dot", "title": "BIOMARKER Node: PDR001"}, {"color": "#D3D3D3", "id": "triple negative breast cancer", "label": "triple negative breast cancer", "shape": "dot", "title": "OTHER Node: triple negative breast cancer"}, {"color": "#FFA07A", "id": "CJM112", "label": "CJM112", "shape": "dot", "title": "BIOMARKER Node: CJM112"}, {"color": "#89CFF0", "id": "BIOLOGIC", "label": "BIOLOGIC", "shape": "dot", "title": "DRUG Node: BIOLOGIC"}, {"color": "#FFA07A", "id": "UNKNOWN", "label": "UNKNOWN", "shape": "dot", "title": "BIOMARKER Node: UNKNOWN"}, {"color": "#FFD700", "id": "Northwestern University", "label": "Northwestern University", "shape": "dot", "title": "SPONSOR Node: Northwestern University"}, {"color": "#D3D3D3", "id": "cervical cancer", "label": "cervical cancer", "shape": "dot", "title": "OTHER Node: cervical cancer"}, {"color": "#FFA07A", "id": "AO-252", "label": "AO-252", "shape": "dot", "title": "BIOMARKER Node: AO-252"}]);
                  edges = new vis.DataSet([{"arrows": "to", "from": "NCT04683679", "label": "sponsored_by", "title": "NCT04683679 \u2192 Memorial Sloan Kettering Cancer Center: sponsored_by", "to": "Memorial Sloan Kettering Cancer Center"}, {"arrows": "to", "from": "NCT04683679", "label": "has_status", "title": "NCT04683679 \u2192 RECRUITING: has_status", "to": "RECRUITING"}, {"arrows": "to", "from": "NCT04683679", "label": "tests", "title": "NCT04683679 \u2192 Pembrolizumab: tests", "to": "Pembrolizumab"}, {"arrows": "to", "from": "Pembrolizumab", "label": "has_type", "title": "Pembrolizumab \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Pembrolizumab", "label": "classified_as", "title": "Pembrolizumab \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "Pembrolizumab", "label": "targets", "title": "Pembrolizumab \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "Pembrolizumab", "label": "targets", "title": "Pembrolizumab \u2192 tnbc - triple-negative breast cancer: targets", "to": "tnbc - triple-negative breast cancer"}, {"arrows": "to", "from": "Pembrolizumab", "label": "targets", "title": "Pembrolizumab \u2192 metastatic breast cancer: targets", "to": "metastatic breast cancer"}, {"arrows": "to", "from": "Pembrolizumab", "label": "targets", "title": "Pembrolizumab \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "Pembrolizumab", "label": "targets", "title": "Pembrolizumab \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT04683679", "label": "tests", "title": "NCT04683679 \u2192 Olaparib: tests", "to": "Olaparib"}, {"arrows": "to", "from": "Olaparib", "label": "has_type", "title": "Olaparib \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Olaparib", "label": "classified_as", "title": "Olaparib \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "Olaparib", "label": "targets", "title": "Olaparib \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "Olaparib", "label": "targets", "title": "Olaparib \u2192 tnbc - triple-negative breast cancer: targets", "to": "tnbc - triple-negative breast cancer"}, {"arrows": "to", "from": "Olaparib", "label": "targets", "title": "Olaparib \u2192 metastatic breast cancer: targets", "to": "metastatic breast cancer"}, {"arrows": "to", "from": "Olaparib", "label": "targets", "title": "Olaparib \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "Olaparib", "label": "targets", "title": "Olaparib \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT04683679", "label": "tests", "title": "NCT04683679 \u2192 Radiation: tests", "to": "Radiation"}, {"arrows": "to", "from": "Radiation", "label": "has_type", "title": "Radiation \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Radiation", "label": "classified_as", "title": "Radiation \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "Radiation", "label": "targets", "title": "Radiation \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "Radiation", "label": "targets", "title": "Radiation \u2192 tnbc - triple-negative breast cancer: targets", "to": "tnbc - triple-negative breast cancer"}, {"arrows": "to", "from": "Radiation", "label": "targets", "title": "Radiation \u2192 metastatic breast cancer: targets", "to": "metastatic breast cancer"}, {"arrows": "to", "from": "Radiation", "label": "targets", "title": "Radiation \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "Radiation", "label": "targets", "title": "Radiation \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT04925284", "label": "sponsored_by", "title": "NCT04925284 \u2192 Exelixis: sponsored_by", "to": "Exelixis"}, {"arrows": "to", "from": "NCT04925284", "label": "has_status", "title": "NCT04925284 \u2192 COMPLETED: has_status", "to": "COMPLETED"}, {"arrows": "to", "from": "NCT04925284", "label": "tests", "title": "NCT04925284 \u2192 XB002: tests", "to": "XB002"}, {"arrows": "to", "from": "XB002", "label": "has_type", "title": "XB002 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "XB002", "label": "classified_as", "title": "XB002 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 scchn: targets", "to": "scchn"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 pancreatic cancer: targets", "to": "pancreatic cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 tissue factor-expressing solid tumors: targets", "to": "tissue factor-expressing solid tumors"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 metastatic castration-resistant prostate cancer: targets", "to": "metastatic castration-resistant prostate cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 esophageal scc: targets", "to": "esophageal scc"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 epithelial ovarian cancer: targets", "to": "epithelial ovarian cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 cervical cancer: targets", "to": "cervical cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 hormone receptor-positive breast cancer: targets", "to": "hormone receptor-positive breast cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 endometrial cancer: targets", "to": "endometrial cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 non small cell lung cancer: targets", "to": "non small cell lung cancer"}, {"arrows": "to", "from": "XB002", "label": "targets", "title": "XB002 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT04925284", "label": "tests", "title": "NCT04925284 \u2192 Nivolumab: tests", "to": "Nivolumab"}, {"arrows": "to", "from": "Nivolumab", "label": "has_type", "title": "Nivolumab \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Nivolumab", "label": "classified_as", "title": "Nivolumab \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 scchn: targets", "to": "scchn"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 pancreatic cancer: targets", "to": "pancreatic cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 tissue factor-expressing solid tumors: targets", "to": "tissue factor-expressing solid tumors"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 metastatic castration-resistant prostate cancer: targets", "to": "metastatic castration-resistant prostate cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 esophageal scc: targets", "to": "esophageal scc"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 epithelial ovarian cancer: targets", "to": "epithelial ovarian cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 cervical cancer: targets", "to": "cervical cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 hormone receptor-positive breast cancer: targets", "to": "hormone receptor-positive breast cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 endometrial cancer: targets", "to": "endometrial cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 non small cell lung cancer: targets", "to": "non small cell lung cancer"}, {"arrows": "to", "from": "Nivolumab", "label": "targets", "title": "Nivolumab \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT04925284", "label": "tests", "title": "NCT04925284 \u2192 Bevacizumab: tests", "to": "Bevacizumab"}, {"arrows": "to", "from": "Bevacizumab", "label": "has_type", "title": "Bevacizumab \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Bevacizumab", "label": "classified_as", "title": "Bevacizumab \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 scchn: targets", "to": "scchn"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 pancreatic cancer: targets", "to": "pancreatic cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 tissue factor-expressing solid tumors: targets", "to": "tissue factor-expressing solid tumors"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 metastatic castration-resistant prostate cancer: targets", "to": "metastatic castration-resistant prostate cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 esophageal scc: targets", "to": "esophageal scc"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 epithelial ovarian cancer: targets", "to": "epithelial ovarian cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 cervical cancer: targets", "to": "cervical cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 hormone receptor-positive breast cancer: targets", "to": "hormone receptor-positive breast cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 endometrial cancer: targets", "to": "endometrial cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 non small cell lung cancer: targets", "to": "non small cell lung cancer"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT06533384", "label": "sponsored_by", "title": "NCT06533384 \u2192 Guangdong Provincial People\u0027s Hospital: sponsored_by", "to": "Guangdong Provincial People\u0027s Hospital"}, {"arrows": "to", "from": "NCT06533384", "label": "has_status", "title": "NCT06533384 \u2192 RECRUITING: has_status", "to": "RECRUITING"}, {"arrows": "to", "from": "NCT06533384", "label": "tests", "title": "NCT06533384 \u2192 As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.: tests", "to": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy."}, {"arrows": "to", "from": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "label": "has_type", "title": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy. \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "label": "classified_as", "title": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy. \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "label": "targets", "title": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy. \u2192 triple-negative breast cancer: targets", "to": "triple-negative breast cancer"}, {"arrows": "to", "from": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy.", "label": "targets", "title": "As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Camrelizumab is made for adjuvant therapy. \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT06533384", "label": "tests", "title": "NCT06533384 \u2192 9 cycles of Camrelizumab as adjuvant therapy.: tests", "to": "9 cycles of Camrelizumab as adjuvant therapy."}, {"arrows": "to", "from": "9 cycles of Camrelizumab as adjuvant therapy.", "label": "has_type", "title": "9 cycles of Camrelizumab as adjuvant therapy. \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "9 cycles of Camrelizumab as adjuvant therapy.", "label": "classified_as", "title": "9 cycles of Camrelizumab as adjuvant therapy. \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "9 cycles of Camrelizumab as adjuvant therapy.", "label": "targets", "title": "9 cycles of Camrelizumab as adjuvant therapy. \u2192 triple-negative breast cancer: targets", "to": "triple-negative breast cancer"}, {"arrows": "to", "from": "9 cycles of Camrelizumab as adjuvant therapy.", "label": "targets", "title": "9 cycles of Camrelizumab as adjuvant therapy. \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT00203502", "label": "sponsored_by", "title": "NCT00203502 \u2192 University of Arkansas: sponsored_by", "to": "University of Arkansas"}, {"arrows": "to", "from": "NCT00203502", "label": "has_status", "title": "NCT00203502 \u2192 COMPLETED: has_status", "to": "COMPLETED"}, {"arrows": "to", "from": "NCT00203502", "label": "tests", "title": "NCT00203502 \u2192 Bevacizumab: tests", "to": "Bevacizumab"}, {"arrows": "to", "from": "Bevacizumab", "label": "has_type", "title": "Bevacizumab \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Bevacizumab", "label": "classified_as", "title": "Bevacizumab \u2192 BIOLOGIC: classified_as", "to": "BIOLOGIC"}, {"arrows": "to", "from": "Bevacizumab", "label": "targets", "title": "Bevacizumab \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "NCT00203502", "label": "tests", "title": "NCT00203502 \u2192 Cyclophosphamide: tests", "to": "Cyclophosphamide"}, {"arrows": "to", "from": "Cyclophosphamide", "label": "has_type", "title": "Cyclophosphamide \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Cyclophosphamide", "label": "classified_as", "title": "Cyclophosphamide \u2192 CHEMICAL: classified_as", "to": "CHEMICAL"}, {"arrows": "to", "from": "Cyclophosphamide", "label": "targets", "title": "Cyclophosphamide \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "NCT00203502", "label": "tests", "title": "NCT00203502 \u2192 Docetaxel: tests", "to": "Docetaxel"}, {"arrows": "to", "from": "Docetaxel", "label": "has_type", "title": "Docetaxel \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "Docetaxel", "label": "classified_as", "title": "Docetaxel \u2192 CHEMICAL: classified_as", "to": "CHEMICAL"}, {"arrows": "to", "from": "Docetaxel", "label": "targets", "title": "Docetaxel \u2192 breast cancer: targets", "to": "breast cancer"}, {"arrows": "to", "from": "NCT06036121", "label": "sponsored_by", "title": "NCT06036121 \u2192 Adcentrx Therapeutics: sponsored_by", "to": "Adcentrx Therapeutics"}, {"arrows": "to", "from": "NCT06036121", "label": "has_status", "title": "NCT06036121 \u2192 RECRUITING: has_status", "to": "RECRUITING"}, {"arrows": "to", "from": "NCT06036121", "label": "tests", "title": "NCT06036121 \u2192 ADRX-0706: tests", "to": "ADRX-0706"}, {"arrows": "to", "from": "ADRX-0706", "label": "has_type", "title": "ADRX-0706 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "ADRX-0706", "label": "classified_as", "title": "ADRX-0706 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "ADRX-0706", "label": "targets", "title": "ADRX-0706 \u2192 solid tumors: targets", "to": "solid tumors"}, {"arrows": "to", "from": "ADRX-0706", "label": "targets", "title": "ADRX-0706 \u2192 cervical cancer: targets", "to": "cervical cancer"}, {"arrows": "to", "from": "ADRX-0706", "label": "targets", "title": "ADRX-0706 \u2192 triple negative breast cancer (tnbc): targets", "to": "triple negative breast cancer (tnbc)"}, {"arrows": "to", "from": "ADRX-0706", "label": "targets", "title": "ADRX-0706 \u2192 urothelial cancer: targets", "to": "urothelial cancer"}, {"arrows": "to", "from": "ADRX-0706", "label": "targets", "title": "ADRX-0706 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT02900664", "label": "sponsored_by", "title": "NCT02900664 \u2192 Novartis Pharmaceuticals: sponsored_by", "to": "Novartis Pharmaceuticals"}, {"arrows": "to", "from": "NCT02900664", "label": "has_status", "title": "NCT02900664 \u2192 COMPLETED: has_status", "to": "COMPLETED"}, {"arrows": "to", "from": "NCT02900664", "label": "tests", "title": "NCT02900664 \u2192 PDR001: tests", "to": "PDR001"}, {"arrows": "to", "from": "PDR001", "label": "has_type", "title": "PDR001 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "PDR001", "label": "classified_as", "title": "PDR001 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "PDR001", "label": "targets", "title": "PDR001 \u2192 colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma: targets", "to": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"arrows": "to", "from": "PDR001", "label": "targets", "title": "PDR001 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT02900664", "label": "tests", "title": "NCT02900664 \u2192 ACZ885: tests", "to": "ACZ885"}, {"arrows": "to", "from": "ACZ885", "label": "has_type", "title": "ACZ885 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "ACZ885", "label": "classified_as", "title": "ACZ885 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "ACZ885", "label": "targets", "title": "ACZ885 \u2192 colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma: targets", "to": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"arrows": "to", "from": "ACZ885", "label": "targets", "title": "ACZ885 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT02900664", "label": "tests", "title": "NCT02900664 \u2192 CJM112: tests", "to": "CJM112"}, {"arrows": "to", "from": "CJM112", "label": "has_type", "title": "CJM112 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "CJM112", "label": "classified_as", "title": "CJM112 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "CJM112", "label": "targets", "title": "CJM112 \u2192 colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma: targets", "to": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"arrows": "to", "from": "CJM112", "label": "targets", "title": "CJM112 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT02900664", "label": "tests", "title": "NCT02900664 \u2192 TMT212: tests", "to": "TMT212"}, {"arrows": "to", "from": "TMT212", "label": "has_type", "title": "TMT212 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "TMT212", "label": "classified_as", "title": "TMT212 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "TMT212", "label": "targets", "title": "TMT212 \u2192 colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma: targets", "to": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"arrows": "to", "from": "TMT212", "label": "targets", "title": "TMT212 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT02900664", "label": "tests", "title": "NCT02900664 \u2192 EGF816: tests", "to": "EGF816"}, {"arrows": "to", "from": "EGF816", "label": "has_type", "title": "EGF816 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "EGF816", "label": "classified_as", "title": "EGF816 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "EGF816", "label": "targets", "title": "EGF816 \u2192 colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma: targets", "to": "colorectal cancer, triple negative breast cancer, nsclc - adenocarcinoma"}, {"arrows": "to", "from": "EGF816", "label": "targets", "title": "EGF816 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT06136884", "label": "sponsored_by", "title": "NCT06136884 \u2192 A2A Pharmaceuticals Inc.: sponsored_by", "to": "A2A Pharmaceuticals Inc."}, {"arrows": "to", "from": "NCT06136884", "label": "has_status", "title": "NCT06136884 \u2192 RECRUITING: has_status", "to": "RECRUITING"}, {"arrows": "to", "from": "NCT06136884", "label": "tests", "title": "NCT06136884 \u2192 AO-252: tests", "to": "AO-252"}, {"arrows": "to", "from": "AO-252", "label": "has_type", "title": "AO-252 \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "AO-252", "label": "classified_as", "title": "AO-252 \u2192 OTHER: classified_as", "to": "OTHER"}, {"arrows": "to", "from": "AO-252", "label": "targets", "title": "AO-252 \u2192 high grade serous ovarian cancer: targets", "to": "high grade serous ovarian cancer"}, {"arrows": "to", "from": "AO-252", "label": "targets", "title": "AO-252 \u2192 endometrial cancer: targets", "to": "endometrial cancer"}, {"arrows": "to", "from": "AO-252", "label": "targets", "title": "AO-252 \u2192 triple negative breast cancer: targets", "to": "triple negative breast cancer"}, {"arrows": "to", "from": "AO-252", "label": "targets", "title": "AO-252 \u2192 TNBC: targets", "to": "TNBC"}, {"arrows": "to", "from": "NCT01372579", "label": "sponsored_by", "title": "NCT01372579 \u2192 Northwestern University: sponsored_by", "to": "Northwestern University"}, {"arrows": "to", "from": "NCT01372579", "label": "has_status", "title": "NCT01372579 \u2192 UNKNOWN: has_status", "to": "UNKNOWN"}, {"arrows": "to", "from": "NCT01372579", "label": "tests", "title": "NCT01372579 \u2192 eribulin mesylate: tests", "to": "eribulin mesylate"}, {"arrows": "to", "from": "eribulin mesylate", "label": "has_type", "title": "eribulin mesylate \u2192 DRUG: has_type", "to": "DRUG"}, {"arrows": "to", "from": "eribulin mesylate", "label": "classified_as", "title": "eribulin mesylate \u2192 CHEMICAL: classified_as", "to": "CHEMICAL"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": false
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>